Skip to main content
Clinical Trials/JPRN-UMIN000034880
JPRN-UMIN000034880
Completed
未知

Clinical studies on antihypertensive drugs used for proteinuria and hypertension intended for the bevacizumab-treated patients - Study on the effectiveness of antihypertensive drugs on proteinuria and hypertension of bevacizumab-treated patients

Iwate Medical University0 sites70 target enrollmentDecember 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
colorectal cancer
Sponsor
Iwate Medical University
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2018
End Date
March 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who have continued therapy with bevacizumab for more than 3 months 2\) Patients who show proteinuria at least once within 4 weeks before consent acquisition 3\) Patients with renal dysfunction of eGFR less than 30 mL / min / 1\.73 m 2 at the time of consent acquisition 4\) Patients who have taken the following medications before consent acquisition: ARB, angiotensin II converting enzyme inhibitor, direct renin inhibitor, diuretic, CCB, alpha / beta antagonist 5\) Patients with diabetes 6\) Patients with cardiovascular disorders 7\) Patients who may be pregnant or pregnant 8\) Patients who are considered difficult to register in this study due to clinically problematic mental illness

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Randomised placebo controlled trial of antihypertensive agents for the prevention of cardiovascular complications of hypertensio
ISRCTN13275753Sponsor not defined - Record provided by the Medical Research Council (UK)4,396
Completed
Not Applicable
Clinical Pharmacological Study to Investigate the Effects of Mucosta Ophthalmic Suspension UD2% on Ocular Surface Cells in Patients with Dry EyeDry eye
JPRN-UMIN000022629Otsuka Pharmaceutical Co., Ltd.15
Not yet recruiting
Not Applicable
A study on fever using therapeutics of fever by H C AlleHealth Condition 1: G969- Disorder of central nervous system, unspecified
CTRI/2024/03/063748Sarada Krishna Homoeopathic medical college
Active, not recruiting
Phase 1
A fibrinogen concentrate study in paediatric patients with inherited fibrinogen deficiencyAfibrinogenaemia or severe hypofibrinogenaemiaMedDRA version: 16.1Level: LLTClassification code 10052651Term: AfibrinogenaemiaSystem Organ Class: 100000004850MedDRA version: 16.1Level: PTClassification code 10051125Term: HypofibrinogenaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2013-000261-36-FRFB Biotechnologies16
Active, not recruiting
Not Applicable
A fibrinogen concentrate study in paediatric patients with inherited fibrinogen deficiencyAfibrinogenaemia or severe hypofibrinogenaemiaMedDRA version: 16.1Level: LLTClassification code 10052651Term: AfibrinogenaemiaSystem Organ Class: 100000004850MedDRA version: 16.1Level: PTClassification code 10051125Term: HypofibrinogenaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2013-000261-36-Outside-EU/EEAFB Biotechnologies12